• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Motor Fluctuations

Articles Collection

  • Movement Disorders
  • Movement Disorders Clinical Practice
MENU 
  • Home
  • Collection
    • Brief Reports
    • Case Reports
    • Editorial
    • Research Articles
    • Revealing Images
    • Reviews
  • Resources
  • About
  • Contact
  • Search
  • This article collection was made possible by Cynapsus.
  • Cynapsus

Editorial

Pharmacological insights into L-DOPA-induced motor fluctuations of patients with Parkinson disease

By Olivier Rascol

Clinical Investigation Center INSERM 1436, Department of Clinical Pharmacology and Neurosciences, University Hospital of Toulouse and University of Toulouse III, UMR Tonic 1214, NS-Park/FCRIN Network and NeuroToul COEN Center of Excellence in Neurodegeneration, Toulouse, France

The discovery 50 years ago of the spectacular efficacy of L-DOPA has revolutionized the treatment of Parkinson disease (PD), and indeed all modern Clinical Pharmacology.  However, within a few years, PD patients on chronic L-DOPA therapy almost inevitably face disabling periods of reduced benefit, known as motor and non-motor “fluctuations” 1. In 2016, adequate management…

Read More

Primary Sidebar

Movement DisordersMovement Disorders is the leading journal on Parkinson’s disease, neurodegenerative & neurodevelopmental disorders & abnormalities in motor control.

Edited By:
Jose A. Obeso, MD, PhD

Movement Disorders Clinical PracticeMovement Disorders Clinical Practice is an online-only journal committed to publishing high quality peer reviewed articles related to clinical aspects of movement disorders.

Edited By:
Kailash Bhatia, MD, DM, FRCP
Marcelo Merello, MD, PhD

Official journals of the

International Parkinson and Movement Disorder Society

Popular

  • Pharmacological insights into L-DOPA-induced motor fluctuations of patients with Parkinson disease

  • Clinical spectrum of levodopa-induced complications

  • New treatments for levodopa-induced motor complications

  • Levodopa-carbidopa intestinal gel in advanced Parkinson’s disease: Final 12-month, open-label results

  • EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson’s Disease

This article collection
was made possible by Cynapsus.
Cynapsus

Footer

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 1999-2025 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
The content on this site is intended for health professionals.